Answers are grounded in this paper and cite their sources.
Introduction: Triple-negative breast cancer (TNBC) has a poor prognosis with a high relapse rate. This study aims to identify predictors of relapse in a Moroccan cohort. Methods: A retrospective study including 130 patients treated between 2016 and 2021. Analysis of clinicopathological characteristics and biological markers (Ki-67, TILs, HER2-low status) was performed. Results: The overall relapse rate was 21.5%. Factors significantly associated with an increased risk were: lymph node involvement (39% vs 7% for N0, p 80% (50% relapse rate, p Discussion: Our results confirm data from the literature regarding the prognostic role of nodal status, Ki-67, and pCR. The predictive value of TILs, particularly moderate levels (11% - 49%), warrants further exploration. Conclusion: This study identifies high-risk subgroups justifying a personalized therapeutic approach, while highlighting the potential of immunological markers as predictive factors.
No takes yet. Share an insight, caveat, or question.
Hilali et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: